Sanofi Genzyme Bioventures

Sanofi-Genzyme BioVentures (SGBV) is the corporate venture capital arm of Sanofi. Previously known as Genzyme Ventures, SGBV has an expanded mandate to invest across the broad business footprint of Sanofi. SGBV only invests in early stage companies with promising new products that may be future Sanofi pipeline candidates. Today, SGBV has assembled a portfolio of direct equity investments in a variety of promising innovative life-science companies.SGBV is an important component of Sanofi’s broader global strategy to invigorate external innovation. In addition to engaging in venture capital, SGBV provides transaction support for equity investments made by other groups within Sanofi.

Your Rating


Leave a Comment

The Business of 3D Printing is Evolving

Don't miss out on opportunities: enter your email to receive news,
updates and exclusive offers directly to your inbox

This information will never be shared with third parties